ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA)
CAPS Rating:
An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.
An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.